when it comes to managing their type 1 diabetes, kids will be kids

Unique clinical burdens for your pediatric patients include:

a need for frequent monitoring and treatment adjustments because of glycemic variability, constant growth, and activity²
difficulty articulating symptoms²
cognitive dysfunction due to daily periods of hypo- and hyperglycemia³
trips to the emergency room due to severe hypo- and hyperglycemia⁴

with Dexcom, your pediatric patients can be free to be a kid

As the CGM with unparalleled flexibility, Dexcom G7 fits into pediatric patients' lives

for patients 2 years and older	first-and-only waterproof CGM^*,5
30-minute warmup, 2x faster than any other CGM^†	first-and-only CGM with direct connectivity to Apple Watch^‡

exceptional accuracy in the moments that matter most⁶

Dexcom defines the gold standard of accuracy^5,7

MARD in pediatrics
Dexcom G7

Using Dexcom CGM in young patients with

type 1 diabetes can lead to:

reduced hypoglycemic events by

48%

increased time in range by

11.1%

within 8 weeks

a clear connection: Dexcom-powered AID leads to improved outcomes^12-14

^{2 Real-world studies put Dexcom CGM to the test}

caring for a child with type 1 diabetes can be overwhelming-
give your caregivers peace of mind with Dexcom G7¹⁵

Dexcom CGM offers multiple features to help protect your pediatric patients:

	Urgent Low Soon		12-hour grace period
	Delay First High Alert		Rise rate
	Dexcom Follow^‡‡		Fall rate

When used to share glucose data with one or more followers, Dexcom Follow is associated with¹⁶:

	lower mean glucose		more time spent in range
	less time in hyper- and hypoglycemia		significantly higher CGM utilization

DEXCOM FOLLOW APP

Dexcom Follow App Screen

get your patients started for free today

Prescribe & Sample

Easily check Dexcom's formulary coverage in your area

Coverage by area or NPI

AID = automated insulin delivery; CGM = continuous glucose monitoring; CIQ = Control-IQ Technology; CLIO = Control-IQ Observational; DKA = diabetic ketoacidosis; MARD = mean absolute relative difference; TIR = time in range.

*The Dexcom G7 Sensor is water-resistant and may be submerged under 8 feet of water for up to 24 hours without failure when properly installed. †Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer. ‡Smart device sold separately. To view a list of compatible devices, visit dexcom.com/compatibility. §In very young children (aged 2-7 years). ||Results obtained with a previous generation Dexcom CGM system and are applicable to G6/G7 given similar feature sets and better performance and usability. ¶In adolescents (aged 16-24 years). #Adverse events were reported monthly over 12 months and were compared to historical data from the T1D Exchange. Patient-reported outcomes were assessed quarterly. All study visits were virtual. **N=9028 using the time-weighted average target of 110 mg/dL. ††Hypoglycemia consensus target of <4% time below 70 mg/dL. ‡‡Separate Follow app and internet connection required.

1 Dexcom, Data on File, 2025. 2 Streisand R, et al. Curr Diab Rep. 2014;14(9):520. 3 Gonder-Frederick LA, et al. Diabetes Care. 2009;32(6):1001-1006. 4 Mulinacci G, et al. Diabetes Technol Ther. 2019;21(1):6-10. 5 Dexcom G7 User Guide, 2023. 6 U.S. Food and Drug Administration, 510(k) Substantial Equivalence Determination Decision Summary, K213919. Published December 7, 2022. 7 FreeStyle Libre 3 User Guide. 8 DiMeglio LA, et al. Diabetes Care. 2021;44(2):464-472. 9 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-147. 10 Thabit H, et al. Diabetes Care. 2020;43(10):2537-2543. 11 U.S. Food and Drug Administration, 510(k) Substantial Equivalence Determination Decision Summary, K222447. Published March 3, 2023. https://www.accessdata.fda.gov/cdrh_docs/reviews/K222447.pdf. 12 Graham R, et al. Diabetes Technol Ther. 2024;26(1):24-32. 13 Breton MD, et al. Diabetes Technol Ther. 2021;23(9):601-608. 14 Forlenza GP, et al. Diabetes Technol Ther. 2024;26(8):514-525. 15 Polonsky WH, et al. J Diabetes Sci Technol. 2022;16(1):97-105. 16 Welsh JB, et al. Diabetes Ther. 2019;10(2):751-755.

Contact Us

If you are a healthcare provider and want to learn more about Dexcom, please fill out the form and a representative will contact you. If you are a Dexcom User or Patient, please contact Dexcom here.

Request a Visit from a Dexcom Representative

Request a G7 Sample

Request Stelo Education Materials

Request Purchasing Info for a Stelo Bulk Order

Please note: To ensure a successful transaction, please provide information that matches the Provider’s medical license information. A valid business address is required for a request to be fulfilled.

Do not include prefix (Mr., Mrs., Dr.)

As listed on Provider’s medical license (no MD, Jr., Sr.)

Please use the Provider’s NPI

Please provide Facility/Office address Only- We will not ship to home address

Is your patient on a connected pump device?

Yes

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense samples of the Dexcom G6 Continuous Glucose Monitoring System and/or Dexcom‘s next generation product, Dexcom G7 (the "Samples"). I represent that I am requesting the Samples for evaluation purposes and that I will not (i) sell, resell, barter, return for credit or seek reimbursement for the use of the Samples, or (ii) for professional services for dispensing or evaluating the Samples, I also agree to inform my patients that they should not submit claims for reimbursement to any third party for any Samples.

The Samples are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither devices nor receivers are included in the Samples. Accordingly, and in light of the applicable G6 or G7 Dexcom Instructions for Use, you should dispense Samples only to a patient who (or whose authorized caregiver), in the exercise of your clinical judgment, (i) has reliable access to a compatible smart device and/or automated insulin delivery system, and (ii) is capable of safely using the Samples with their smart device, without the need for a separate dedicated receiver.

Please note that Medicare will reimburse for sensors only if the beneficiary also uses a receiver covered by Medicare. Accordingly, it is appropriate to give Samples to Medicare patients only if they have (in the case of the G6 Samples) or would be eligible to obtain (in the case of the G7 Samples), a Medicare-covered receiver.

You agree that you will not provide the Samples to any patients that are beneficiaries under the Maine or Colorado state Medicaid programs. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Samples. I agree not to reuse any Samples. I acknowledge that Dexcom provides no warranties for the Samples other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Samples, and I agree to store and use these Samples in a manner consistent with the applicable Dexcom Instructions for Use. Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

LBL-1004145 Rev001

By submitting the above form, I certify that I am a licensed practitioner, authorized to receive and dispense these Dexcom G6 Continuous Glucose Monitoring Systems and/or Dexcom‘s next generation product, Dexcom G7 (the "Dexcom Education Devices") which are provided in the quantities listed above.

The Dexcom Education Devices are FDA cleared for use with a compatible smart device or separate piece of durable medical equipment called a receiver. Neither smart devices nor receivers are included with the Dexcom Education Devices. I understand that these Dexcom Education Devices are being requested for me and other healthcare professionals ("HCPs") for evaluation purposes to learn more about the Dexcom Education Devices and experience the benefits of the Dexcom Education Devices through a product demonstration, and that each HCP will need a compatible smart device for the product demonstration.

I acknowledge that Dexcom provides no warranties for the Dexcom Education Devices other than the warranties outlined in the applicable Dexcom Instructions for Use. I will comply with all applicable federal, state and local laws in receiving and dispensing these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use, and agree not to reuse any Dexcom Education Devices. I agree to receive, store, distribute, and/or use these Dexcom Education Devices in a manner consistent with the applicable Dexcom Instructions for Use and device labeling. I understand that Dexcom will be tracking, and if necessary, reporting and may be subject to disclosure requirements with respect to the provision of these Dexcom Education Devices. I understand and agree to properly dispose of the Dexcom Education Devices immediately following the completion of the product demonstration. The Dexcom Education Devices are being provided at no cost, without any expectation of remuneration, HCPs have no obligations under the federal supply schedule contract for participating in the product demonstration, and Dexcom waives any rights under this contract or applicable law to pursue a claim for the costs associated with the Dexcom Education Devices.

Dexcom is a registered trademark of Dexcom, Inc. in the United States and/or other countries. ©2023 Dexcom, Inc. All rights reserved.

By choosing to request info, you are granting Dexcom, Inc. permission to process your personal information to send you additional information and promotional communications related to Dexcom products. You may opt-out of these communications at any time. Dexcom respects the privacy and confidentiality of your personal information. The information you provide will be sent securely and subject to the Dexcom Terms of Use and Privacy Policy.